Overview

Metformin And Longevity

Status:
Unknown status

Trial end date:
2017-07-01

Target enrollment:

Participant gender:

Summary

This is a randomized, placebo-controlled, double-blind, window of opportunity study investigating the biological mechanism of metformin in prostate cancer.

Phase:

Phase 4

Details

Lead Sponsor:

Guy's and St Thomas' NHS Foundation Trust

Collaborator:

King's College London

Treatments:

Metformin